Biostar Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Gross
Biostar Pharmaceuticals, Inc. had Finite-Lived Intangible Assets, Gross of $18.14 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2017-11-20
- 2017-09-30: Finite-Lived Intangible Assets, Gross $18.14M.
- 2017-06-30: Finite-Lived Intangible Assets, Gross $17.81M.
- 2017-03-31: Finite-Lived Intangible Assets, Gross $17.57M.
- 2016-12-31: Finite-Lived Intangible Assets, Gross $17.50M.
| Period end | Finite-Lived Intangible Assets, Gross |
|---|---|
| 2017-09-30 | $18.14M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $17.81M 10-Q · filed 2017-11-15 |
| 2017-03-31 | $17.57M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $17.50M 10-Q · filed 2017-11-20 |
| 2016-09-30 | $18.35M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $18.52M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $19.21M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $19.15M 10-K · filed 2017-04-13 |
| 2015-09-30 | $21.39M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $22.75M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $22.66M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $22.53M 10-K · filed 2016-04-14 |
| 2014-09-30 | $22.50M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $22.49M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $22.46M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $22.65M 10-K · filed 2015-04-15 |
| 2013-09-30 | $22.74M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $22.60M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $12.41M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $12.34M 10-K · filed 2014-03-31 |
| 2012-09-30 | $12.26M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $12.26M 10-Q · filed 2012-08-14 |
| 2011-12-31 | $12.26M 10-K · filed 2013-04-15 |